4//SEC Filing
Van Naarden Jacob 4
Accession 0000059478-24-000058
CIK 0000059478other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:41 PM ET
Size
7.9 KB
Accession
0000059478-24-000058
Insider Transaction Report
Form 4
Van Naarden Jacob
EVP & Pres., Lilly Oncology
Transactions
- Award
Common Stock
2024-02-12$737.26/sh+2,369$1,746,569→ 16,147 total - Award
Restricted Stock Unit
2024-02-12+3,023→ 3,023 totalFrom: 2025-02-01Exp: 2025-02-01→ Common Stock (3,023 underlying)
Holdings
- 4,342(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001661254
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:41 PM ET
- Size
- 7.9 KB